Barranco CRS (Site ID: 11301)

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Tuberculosis2 trials
• HIV1 trial

Phase

• Phase 22 trials
• Phase 11 trial

Status

• Not yet recruiting2 trials
• Completed1 trial

Lead sponsor

• National Institute of Allergy and Infectious Diseases (NIAID)3 trials

Running trials

• Recruiting

  A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies

  NCT07569029· Phase 1· National Institute of Allergy and Infectious Diseases (NIAID)· Source

  Contact: Consuelo T. Ramirez

• Recruiting

  Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

  NCT05383742· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

  Contact: María Caballero, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV1 recruiting
• Tuberculosis1 recruiting

Closed trials

• Completed

  Linezolid Dosing Strategies in Drug-Resistant TB

  NCT05007821· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source